Avania is the only global CRO built for MedTech — integrating regulatory strategy, clinical development, and market access and reimbursement to take innovations from concept to commercialization with confidence. Avania was purpose-designed to serve medical technology innovators, combining regulatory, clinical, engineering, and market access expertise to guide products across the full lifecycle. We bring deep experience across a wide range of therapeutic areas, with particular strength in cardiovascular, neurovascular, and orthopedics: three of MedTech’s most complex and high-growth fields. Avania combines international reach with deep local expertise. Our regional teams understand the regulatory, cultural, and operational nuances that accelerate approvals and improve site engagement worldwide. Partner with Avania and experience the difference of a MedTech-only CRO: trusted expertise, collaborative engagement, and proven results.
| Website | https://www.avaniaclinical.com/ |
| Revenue | $70.4 million |
| Employees | 384 (4 on RocketReach) |
| Address | 100 Crowley Suite 216, Marlborough, Massachusetts 01752, US |
| Industry | Medical Equipment Manufacturing |
| Competitors | Celerion, Research Pharmaceutical Services, ICON plc, Syneos Health, Medpace, Covance, Worldwide Clinical Trials, Charles River Laboratories, IQVIA, Withings +33 more (view full list) |
Looking for a particular Avania employee's phone or email?
The Avania annual revenue was $70.4 million in 2026.
Megan Williams is the Associate Director Biostatistics of Avania.
4 people are employed at Avania.
Avania is based in Marlborough, Massachusetts.